| Margins | Operational performance improvements managed steadily over last 8 years. |
|---|---|
| Demand visibility | Strong hospital service demand; patients unaffected by shareholding legalities. |
| Management confidence | High; confident in legal compliance and operational insulation from court proceedings. |
Growth
No quarterly financial metrics (Revenue/PAT) reported for Q1 FY27; focus remains on long-term India growth engine.
Outlook
IHH committed to increasing stake to 50%+ and integrating Gleneagles; brownfield expansion plans continue as scheduled.
Risks
Potential 6-month forensic audit timeline; legal expenses estimated at approximately INR 25 crores annually.
Earnings Call Transcript filed with BSE, NSE: FORTIS. Summary written with AI assistance from the document.
Fortis Healthcare Ltd: key numbers
- Share price
- ₹779.10
- Market cap
- ₹58,819 Cr
- Revenue (annual)
- ₹9,128 Cr
- Net profit (annual)
- ₹1,042 Cr
- P/E (TTM)
- 56.1×Sector 53.1×
- Promoter holding
- 31.17%+0.00% QoQ
- FII holding
- 25.20%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Fortis Healthcare Ltd
All →Fortis Healthcare Legal & Regulatory
Northern TK Venture Pte Ltd, Fortis Healthcare's promoter, has appealed a Tokyo District Court judgment to the Tokyo High Court. The litigation concerns losses related to delayed tender offer approvals.
Fortis Healthcare Partnership
Fortis Hospotel signed definitive agreements with SLJ Society to provide healthcare services at their 400+ bed hospital. Fortis will provide a ₹567 Crore loan.
- Value
- ₹567.0 Cr
- From
- Seth Sunder Lal Jain Charitable Eye Hospital (SLJ Society)
- hospital beds
- 400.0 beds
Fortis Healthcare Legal & Regulatory
Tokyo District Court dismissed all NTK claims against Daiichi Sankyo; NTK must bear litigation costs. NTK is reviewing the judgment and evaluating appeal options.
Fortis Healthcare Legal & Regulatory
The Delhi High Court has ordered a forensic audit concerning shareholding changes and control of Fortis Healthcare's erstwhile promoters. The company faces no liability or penalty.
Fortis Healthcare Other Announcement
Fortis Healthcare Limited received a voluntary ESG rating for FY 2025-26 from Crisil ESG Ratings & Analytics Ltd, with a rating category of 'Strong'.
Fortis Healthcare Annual General Meeting
Fortis Healthcare held its 30th Annual General Meeting on August 11, 2026. Shareholders considered resolutions for financial statement adoption, a Rs. 1 per share dividend, and director re-appointments.